GlaxoSmithKline (GSK), a leading global supplier of prescription medications and vaccines, introduced the OnSign eSignature platform in 2020. Initially, the adoption was to address the signing of various certification documents for return-to-work procedures amidst the outbreak of the novel coronavirus. However, presently, its use has expanded to include the signing of service verification documents with doctors, speaker contracts, pharmaceutical research and development, informed consent with patients, clinical research protocols, project commissioning signatures with hospitals, and even human resource scenarios like employment verification, resignation verification, income proof, and promotion notifications. This has enhanced the company's online business process capabilities.